≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

Endpoint Browser

C3_PERIPHERAL_NERVES_AUTONOMIC3_NERVESYSTEM_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C47
  • Hospital discharge: ICD-9 — 1928
  • Hospital discharge: ICD-8 — 192[4-5]
  • Cause of death: ICD-10 — C47
  • Cause of death: ICD-9 — 1928
  • Cause of death: ICD-8 — 192[4-5]
  • Cancer registry: Topography ICD-O-3 — C47
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

130

4. Check minimum number of events

None

130

5. Include endpoints

None

130

6. Filter based on genotype QC (FinnGen only)

125

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 125 62 63
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 52.22 49.58 54.82

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
130
Matched controls
1300
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
46.7
42
*
H02AB02
ATC
dexamethasone; systemic
70.6
25.2
28
5
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
291.5
24.5
24
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
18.2
19.3
30
21
A03FA01
ATC
metoclopramide; systemic, rectal
6.4
19.0
39
82
C47.30
ICD-10 Finland
Malignant tumor of peripheral nerves of the thorax without histology
+∞
18.1
17
*
TPH07
NOMESCO Finland
Cathetrisation of artery
7.2
17.0
29
50
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
26.1
16.2
22
10
ZXE20
NOMESCO Finland
More than three and less than five hours
5.7
15.9
36
82
JN4AD
NOMESCO Finland
Body CT examination
12.2
14.3
26
26
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
13.8
13
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
13.8
13
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
155.6
13.7
14
*
A04AA02
ATC
granisetron; systemic, transdermal
155.6
13.7
14
*
L03AA02
ATC
filgrastim; parenteral
+∞
12.7
12
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
12.7
12
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
+∞
12.7
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
143.3
12.7
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
12.2
77
367
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
11.6
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.6
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
131.1
11.6
12
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
12.9
11.5
20
18
WF002
NOMESCO Finland
Radical radiotherapy
65.5
10.8
12
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
65.5
10.8
12
*
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
+∞
10.6
10
*
C47.16
ICD-10 Finland
Malignant tumor of the peripheral nerves of the upper extremity including the shoulder neurilemmoma
+∞
10.6
10
*
ZZR00
NOMESCO Finland
Flap of skin
+∞
10.6
10
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.4
10.2
55
232
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
10.2
48
186
JN4BD
NOMESCO Finland
Extensive body CT
9.1
10.1
21
27
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.6
9.7
20
41
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
107.5
9.5
10
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
107.5
9.5
10
*
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
+∞
9.5
9
*
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
9.5
9
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
9.3
62
293
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.5
9.0
38
136
Z3226
NOMESCO Finland
Physiotherapist
3.3
8.5
40
153
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C47.39
ICD-10 Finland
Malignant tumor of peripheral nerves of the thorax other or unspecified tumor
+∞
8.4
8
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
9500/3-C47.3
ICD-O-3
Neuroblastoma, NOS, of peripheral nerves and autonomic nervous system of thorax
+∞
8.4
8
*
116
Kela drug reimbursment
Prostate cancer
+∞
8.4
8
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
35.8
8.2
10
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
23.8
8.2
11
5
A04AA01
ATC
ondansetron; systemic, rectal
11.0
7.7
14
14
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
14.5
7.5
12
9
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
7.4
7
*
C47.00
ICD-10 Finland
Malignant tumor of the peripheral nerves of the head, face and neck without histology
+∞
7.4
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.4
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.4
7
*
C47.3
ICD-10 Finland
Malignant neoplasm: Peripheral nerves of thorax
+∞
7.4
7
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.4
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.4
7
*
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
+∞
7.4
7
*
19251
ICD-8 Finland
Malignant neoplasm of other part of nervous system, Sympathetic nervous system
+∞
7.4
7
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
32.0
7.2
9
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.8
7.1
24
73
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
7.4
7.1
16
24
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
7.0
30
107
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
6.8
17
41
WX402
NOMESCO Finland
General anaesthesia
3.2
6.7
32
122
XX3DW
NOMESCO Finland
Time consuming IT work
7.2
6.6
15
23
Z3231
NOMESCO Finland
Registered nurse
2.7
6.5
45
210
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
6.5
35
143
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.0
6.4
12
13
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
19.2
6.4
9
5
9500/3-C47.4
ICD-O-3
Neuroblastoma, NOS, of peripheral nerves and autonomic nervous system of abdomen
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
9560/3-C47.9
ICD-O-3
Neurilemoma, malignant of autonomic nervous system, NOS
+∞
6.3
6
*
C47.19
ICD-10 Finland
Malignant tumor of the peripheral nerves of the upper extremity including the shoulder other or unspecified tumor
+∞
6.3
6
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
6.3
6
*
R4110
NOMESCO Finland
Physiotherapy
2.7
6.1
43
202

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
71
315
3.76
12.66
2.5
1.6
—
—
—
0
0
22
32
8.05
9.83
1.5
1.2
—
—
—
0
0
32
104
3.76
8.71
8.7
5.0
106.44
104.41
mmol/l
2.22
32
104
79
450
2.93
8.16
8.8
5.5
1.19
1.22
mmol/l
2.14
73
385
27
83
3.84
7.91
1.4
1.0
—
—
—
0
0
89
559
2.88
7.34
10.1
5.7
4.31
4.31
e9/l
0.00
82
474
10
5
21.48
7.25
5.2
1.4
19.27
12.18
ug/l
—
10
5
19
48
4.46
7.18
7.8
7.9
0.64
0.76
%
0.56
19
48
47
224
2.72
6.54
4.2
3.0
90.09
91.38
%
0.13
47
219
18
49
4.10
6.17
8.1
7.8
1.20
1.74
%
0.97
18
49
53
277
2.54
6.05
5.6
2.0
2.35
2.36
mmol/l
0.20
44
237
54
285
2.53
6.03
4.1
3.2
25.28
51.26
e6/l
0.72
42
216
53
280
2.51
5.88
4.6
2.8
7.39
7.40
ph
—
8
44
46
229
2.56
5.77
3.8
3.8
—
—
—
0
0
69
418
2.39
5.59
13.2
11.6
1.17
1.23
inr
0.30
17
124
58
332
2.35
5.28
4.7
3.7
55.07
41.93
e6/l
0.19
45
227
21
75
3.15
4.82
7.9
7.7
—
—
—
0
0
28
121
2.67
4.58
2.0
1.9
—
—
—
0
0
48
267
2.26
4.55
2.9
1.9
—
—
—
0
0
37
184
2.41
4.53
3.8
2.9
546.29
562.36
mosm/kgh2o
0.14
31
151
14
33
4.63
4.48
6.6
6.4
—
—
—
0
0
47
261
2.25
4.46
4.6
3.1
0.31
0.24
e6/l
0.20
38
190
44
239
2.27
4.39
9.1
4.5
—
—
—
0
0
76
516
2.14
4.29
6.1
5.0
1.87
1.91
e9/l
0.13
68
450
45
254
2.18
4.05
4.5
3.0
—
—
—
0
0
74
506
2.07
4.00
6.2
4.9
0.55
0.59
e9/l
0.66
65
431
16
55
3.18
3.89
4.3
4.6
1.60
0.27
%
—
5
11
17
61
3.06
3.86
4.5
4.4
1.67
0.62
%
—
6
13
68
458
2.02
3.76
5.8
5.5
—
—
—
0
0
9
16
5.95
3.73
2.2
1.6
—
—
—
0
0
73
508
2.00
3.64
6.3
4.9
0.04
0.04
e9/l
1.16
64
431
30
149
2.32
3.63
3.7
3.0
2.46
2.20
e6/l
0.06
17
76
12
31
4.16
3.60
3.7
2.8
—
—
—
0
0
74
522
1.97
3.50
6.6
5.0
0.21
0.20
e9/l
0.12
66
446
16
60
2.90
3.37
4.8
4.4
0.20
0.08
%
—
5
12
14
49
3.08
3.31
5.1
3.7
—
—
—
0
0
10
25
4.24
3.16
1.3
1.0
—
—
—
0
0
6
8
7.79
3.09
2.3
3.0
4.65
6.67
nmol/l
—
6
8
17
71
2.60
2.94
5.6
4.5
63.36
86.90
ng/l
1.22
17
59
87
673
1.88
2.88
5.5
3.7
—
—
—
0
0
16
66
2.62
2.84
7.8
9.1
23.86
25.32
mmol/l
1.05
16
66
65
469
1.77
2.62
10.1
7.3
0.03
0.00
e9/l
0.49
54
374
93
757
1.80
2.36
3.5
3.7
11.81
10.85
mm/h
0.30
83
688
6
13
4.78
2.30
2.7
1.3
—
—
—
0
0
6
13
4.78
2.30
2.7
1.5
—
—
—
0
0
19
96
2.15
2.19
2.7
2.0
390.58
384.43
nmol/l
0.05
19
89
51
360
1.69
2.12
3.6
3.6
56.24
49.03
ng/l
0.08
35
255
5
10
5.15
2.09
1.4
2.2
—
—
—
0
0
5
11
4.68
1.96
1.4
1.0
—
—
—
0
0
16
79
2.17
1.95
1.8
2.8
—
—
—
0
0
80
644
1.63
1.93
5.8
4.0
—
451.25
—
0
8
14
66
2.26
1.90
1.3
1.3
—
—
—
0
0
5
12
4.29
1.84
2.8
1.4
—
—
nmol/l
—
0
0
5
13
3.95
1.73
1.6
1.3
38.95
293.23
u/ml
—
5
13
5
13
3.95
1.73
1.4
2.2
—
—
—
0
0
40
278
1.63
1.72
4.2
2.7
—
—
—
0
0
7
25
2.90
1.67
6.4
3.8
3.84
3.82
mmol/l
—
7
25
91
776
1.58
1.56
4.7
3.8
15.05
14.91
pmol/l
0.22
82
697
5
15
3.42
1.54
3.0
2.6
—
—
—
0
0
60
474
1.49
1.43
3.7
3.4
0.00
0.00
estimate
—
7
76
32
220
1.60
1.42
2.8
3.5
—
—
—
0
0
59
467
1.48
1.38
3.7
3.4
0.00
0.00
estimate
—
8
89
51
392
1.50
1.38
2.0
1.8
83.55
96.25
pmol/l
1.12
24
182
40
292
1.53
1.37
3.0
2.1
127.60
187.39
u/l
0.56
40
269
26
172
1.64
1.34
1.6
1.7
925.21
1169.10
nmol/l
0.68
21
125
5
18
2.85
1.29
1.8
1.9
18.64
16.80
%
—
5
9
80
678
1.47
1.29
4.5
3.5
—
—
—
0
0
58
468
1.43
1.19
5.0
4.7
0.00
0.00
estimate
—
7
81
113
1037
1.69
1.19
18.8
10.9
30.93
23.37
mg/l
1.27
103
759
5
20
2.56
1.16
1.2
1.9
—
—
—
0
0
40
304
1.46
1.12
6.5
3.6
2.21
1.97
ug/l
0.15
34
272
7
35
2.06
1.01
6.7
3.3
—
—
—
0
0
10
55
1.89
0.95
1.4
1.2
—
—
—
0
0
41
322
1.40
0.95
3.8
3.2
6.45
7.74
mmol/l
1.83
35
263
6
29
2.12
0.90
1.3
1.1
—
—
—
0
0
6
31
1.98
0.85
1.5
1.1
—
—
—
0
0
15
98
1.60
0.83
1.5
1.3
—
—
—
0
0
26
195
1.42
0.77
1.5
1.6
2.09
1.26
mg/l
0.30
16
146
7
38
1.89
0.75
1.1
1.1
36.67
37.79
g/l
—
7
33
11
68
1.67
0.74
3.1
2.8
0.23
0.20
g/l
0.67
11
57
12
77
1.62
0.71
4.2
3.6
—
—
—
0
0
5
27
1.88
0.69
3.2
3.3
—
—
—
0
0
102
948
1.35
0.68
5.5
4.5
1.97
1.92
mu/l
0.15
91
851
7
44
1.62
0.66
1.0
1.2
—
—
—
0
0
116
1103
1.48
0.65
25.5
12.3
79.11
76.72
umol/l
0.36
116
1103
5
29
1.75
0.64
1.0
1.1
—
—
—
0
0
36
294
1.31
0.64
3.1
3.3
88.86
78.72
mg/l
0.07
22
190
30
240
1.32
0.61
4.2
3.8
0.00
0.00
estimate
—
7
79
0
21
0.00
0.60
0.0
5.7
—
31.73
—
0
13
6
35
1.75
0.58
1.2
1.2
1.14
1.12
g/l
—
6
35
6
35
1.75
0.58
6.7
7.1
—
—
—
0
0
20
258
0.73
0.57
1.7
1.5
—
—
—
0
0
103
967
1.31
0.57
4.1
3.9
1.22
1.23
mmol/l
0.08
92
880
114
1087
1.40
0.55
19.1
9.8
—
—
—
0
0
17
127
1.39
0.53
1.5
1.7
—
—
—
0
0
15
110
1.41
0.51
1.3
1.4
—
—
—
0
0
106
1004
1.30
0.51
4.5
4.4
4.42
4.58
mmol/l
0.84
99
929
37
314
1.25
0.49
3.3
4.0
11.88
10.37
mg/mmol
0.10
23
198
7
47
1.52
0.48
3.6
2.9
—
—
—
0
0
34
287
1.25
0.47
4.4
3.6
—
—
—
0
0
104
989
1.26
0.43
4.7
4.3
5.89
5.97
mmol/l
0.30
95
902
27
225
1.25
0.41
1.6
1.5
16.21
21.64
nmol/l
1.54
21
193
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.49
0.41
1.2
1.2
0.18
0.24
g/l
—
5
34
8
111
0.70
0.39
1.9
1.8
—
—
—
0
0
5
36
1.40
0.38
2.0
2.0
0.70
0.59
%
—
5
36
104
995
1.23
0.36
4.4
4.4
1.41
1.47
mmol/l
0.72
94
915
10
74
1.38
0.33
1.0
1.2
—
—
—
0
0
12
92
1.34
0.33
1.4
1.4
—
—
—
0
0
7
55
1.29
0.30
3.0
2.4
—
—
—
0
0
7
56
1.26
0.30
3.4
8.0
—
—
—
0
0
5
73
0.67
0.27
1.2
1.3
—
40.80
—
0
5
9
74
1.23
0.26
1.1
1.4
—
—
—
0
0
12
97
1.26
0.24
1.8
1.4
—
—
—
0
0
5
38
1.33
0.23
2.0
2.1
0.92
1.08
%
—
5
38
98
946
1.15
0.23
5.4
5.9
38.83
40.06
mmol/mol
0.70
90
875
19
218
0.85
0.21
1.1
1.4
1.98
2.35
g/l
—
8
117
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
23
205
1.15
0.18
1.6
1.7
431250408.19
449.61
pmol/l
0.48
16
159
6
75
0.79
0.16
6.7
3.6
—
—
—
0
0
119
1172
1.18
0.14
31.5
15.8
39.63
40.57
%
0.92
112
1097
119
1173
1.17
0.13
30.9
15.8
4.47
4.57
e12/l
1.31
114
1132
119
1174
1.16
0.12
31.0
15.7
6.82
6.73
e9/l
0.15
114
1134
104
1021
1.09
0.11
5.2
4.9
2.59
2.70
mmol/l
0.60
94
940
14
156
0.89
0.10
1.5
1.3
22.07
9.66
u/ml
—
6
48
33
348
0.93
0.09
3.2
3.2
—
—
—
0
0
6
56
1.07
0.09
1.8
2.0
—
—
—
0
0
9
86
1.05
0.07
1.1
1.2
—
—
—
0
0
9
104
0.86
0.06
1.2
1.5
—
—
—
0
0
18
168
1.08
0.06
2.6
2.5
0.84
0.68
ug/l
—
9
113
10
106
0.94
0.01
2.3
1.9
—
—
—
0
0
12
126
0.95
0.00
1.5
1.2
—
—
—
0
0
14
141
0.99
0.00
2.3
1.6
—
—
—
0
0
26
261
1.00
0.00
4.4
3.0
—
—
—
0
0
19
193
0.98
0.00
1.9
1.9
—
—
—
0
0
27
265
1.02
0.00
1.6
1.7
1.38
1.36
mmol/l
0.04
21
217
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
73.13
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
391.00
—
0
7
0
6
0.00
-0.00
0.0
2.3
—
12.87
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
70
1.00
-0.00
1.1
2.0
11.03
10.28
g/l
—
7
65
0
6
0.00
-0.00
0.0
10.2
—
0.65
—
0
6
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
12.2
—
1679.00
—
0
6
0
9
0.00
-0.00
0.0
2.3
—
1802.22
—
0
9
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
11.8
—
890.33
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
26.00
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
126.20
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_PERIPHERAL_NERVES_AUTONOMIC3_NERVESYSTEM_WIDE – Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).